RECRUITING

Intravenous Fluids in Pediatric Migraine

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to compare intravenous (IV) fluids in pediatric patients with migraine. The main questions it aims to answer are: * Does a large amount of fluids (bolus) improve pain * Does a large amount of fluids (bolus) reduce admissions to the hospital for migraine Participants will be asked to report their pain and have vital signs checked every 30 minutes for two hours. Researchers will compare a large amount of fluids (bolus) to a small amount (half maintenance) to see if there is a difference in pain improvement.

Official Title

Value of Intravenous Fluids in the Emergent Treatment of Pediatric Migraine

Quick Facts

Study Start:2023-06-27
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06182098

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:5 Years to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * At least 1 prior headache
  2. * Minimum pain score of 10mm
  3. * Headache lasting 2-72 hours
  4. * At least two of the following four: 1 Bifrontal/bitemporal or unilateral location, 2 Pulsating quality, 3 Moderate or severe pain intensity, 4 Aggravation by or causing avoidance of routine physical activity
  5. * At least one of the following: 1 Nausea and/or vomiting, 2Photophobia and phonophobia, 3 Not better accounted for by another ICHD-3 diagnosis
  1. * Shunted hydrocephalus
  2. * Temperature equal to or greater than 38.5C
  3. * Clinical suspicion of meningitis
  4. * Known or suspected intracranial lesion
  5. * Clinical evidence of significant dehydration (or signs of shock, or attending discretion)
  6. * Head trauma in previous 7 days
  7. * Pregnancy or breastfeeding
  8. * Initial pain score less than 10mm
  9. * Allergy to study medications
  10. * Patients previously participating in the study

Contacts and Locations

Study Contact

Jonathan Elliott, MD
CONTACT
(812) 582-3059
elliottj1@childrensdayton.org

Principal Investigator

Jonathan Elliott, MD
PRINCIPAL_INVESTIGATOR
Dayton Children's

Study Locations (Sites)

Dayton Children's Hosptial
Dayton, Ohio, 45404
United States

Collaborators and Investigators

Sponsor: Dayton Children's Hospital

  • Jonathan Elliott, MD, PRINCIPAL_INVESTIGATOR, Dayton Children's

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-27
Study Completion Date2025-06

Study Record Updates

Study Start Date2023-06-27
Study Completion Date2025-06

Terms related to this study

Keywords Provided by Researchers

  • migraine
  • headache
  • pediatric
  • fluids
  • bolus

Additional Relevant MeSH Terms

  • Migraine
  • Migraine in Children